BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11231495)

  • 1. Natural killer cell precursor acute lymphoma/leukemia presenting in an infant.
    Natkunam Y; Cherry AM; Cornbleet PJ
    Arch Pathol Lab Med; 2001 Mar; 125(3):413-8. PubMed ID: 11231495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study.
    DiGiuseppe JA; Louie DC; Williams JE; Miller DT; Griffin CA; Mann RB; Borowitz MJ
    Am J Surg Pathol; 1997 Oct; 21(10):1223-30. PubMed ID: 9331296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
    Suzuki R; Nakamura S
    Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.
    Alvarez-Larrán A; Villamor N; Hernández-Boluda JC; Ferrer A; Camós M; Campo E; López-Guillermo A
    Clin Lymphoma; 2001 Dec; 2(3):178-82; discussion 183-4. PubMed ID: 11779295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
    Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
    Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hybrid form of myeloid/NK-cell acute leukemia and myeloid/NK-cell precursor acute leukemia.
    Sun T; Pashaei S; Jaffrey I; Ryder J
    Hum Pathol; 2003 May; 34(5):504-8. PubMed ID: 12792926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenge in diagnosis of CD56+ lymphoproliferative disorders: two cases of CD56+CD33+ lymphoma/leukemia.
    Yang X; Wasserman PG; Bhargava A; Iqbal U; Ragnauth S; Fuchs A
    Arch Pathol Lab Med; 2004 Aug; 128(8):e100-3. PubMed ID: 15270596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric myeloid/NK cell precursor lymphoma/leukemia expressing T/NK immunophenotype markers.
    Hashii Y; Okuda T; Ohta H; Ozono K; Hara J
    Int J Hematol; 2010 Apr; 91(3):525-9. PubMed ID: 20146030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
    Suzuki R; Yamamoto K; Seto M; Kagami Y; Ogura M; Yatabe Y; Suchi T; Kodera Y; Morishima Y; Takahashi T; Saito H; Ueda R; Nakamura S
    Blood; 1997 Sep; 90(6):2417-28. PubMed ID: 9310493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncommon cases of immature-type CD56+ natural killer (NK)-cell neoplasms, characterized by expression of myeloid antigen of blastic NK-cell lymphoma.
    Owatari S; Otsuka M; Takeshita T; Mizukami K; Suzuki S; Uozumi K; Tashiro Y; Arima N; Hanada S
    Int J Hematol; 2009 Mar; 89(2):188-194. PubMed ID: 19109730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric acute blastic natural killer cell leukemia.
    DuBois SG; Etzell JE; Matthay KK; Robbins E; Banerjee A
    Leuk Lymphoma; 2002 Apr; 43(4):901-6. PubMed ID: 12153184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer-cell lymphoma involving the gynecologic tract.
    Mhawech P; Medeiros LJ; Bueso-Ramos C; Coffey DM; Gei AF; Shahab I
    Arch Pathol Lab Med; 2000 Oct; 124(10):1510-3. PubMed ID: 11035585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute T-lymphoblastic leukemia relapsed with the character of myeloid/natural killer cell precursor phenotype: a case report.
    Hashimoto S; Toba K; Aoki S; Tsuchiyama J; Tsukada N; Takahashi H; Takahashi M; Aizawa Y
    Leuk Res; 2002 Feb; 26(2):215-9. PubMed ID: 11755472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.
    Shapiro M; Wasik MA; Junkins-Hopkins JM; Rook AH; Vittorio CC; Itakura H; Frankel MC; Georgala S; Schuster SJ
    Am J Hematol; 2003 Sep; 74(1):46-51. PubMed ID: 12949889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal CD56 positive small round cell tumors. Differential diagnosis of hematological, neurogenic, and myogenic neoplasms.
    Liu Q; Ohshima K; Sumie A; Suzushima H; Iwasaki H; Kikuchi M
    Virchows Arch; 2001 Mar; 438(3):271-9. PubMed ID: 11315624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement.
    Nagata T; Higashigawa M; Nagai M; Zhang XL; Azuma E; Komada Y; Sakurai M
    Leuk Res; 1996; 20(11-12):983-5. PubMed ID: 9009257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High grade malignant lymphoma with clinical characteristics and immunophenotype of natural killer cells.
    Schleiffenbaum B; Rüegg R; Zimmermann D; Fehr J
    Am J Hematol; 1995 Jul; 49(3):221-31. PubMed ID: 7541603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five Chinese pediatric patients with leukemias possibly arising from immature natural killer cells: clinical features and courses.
    Guan XQ; Xu L; Ke ZY; Huang LB; Zhang XL; Zhang YC; Luo XQ
    Pediatr Hematol Oncol; 2011 Apr; 28(3):187-93. PubMed ID: 21271777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of primary cutaneous CD56+, TdT+, CD4+, blastic NK-cell lymphoma in a 19-year-old woman.
    Chang SE; Choi HJ; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
    Am J Dermatopathol; 2002 Feb; 24(1):72-5. PubMed ID: 11803287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.